NASDAQ NMS - GLOBAL MARKET · PASG
+0.00% · +$0.0000 · Vol 6.8K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Passage Bio Inc

Passage Bio Inc

Biotechnology
$4.40
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
PASG
Passage Bio Inc
Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

73/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is PASG moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading PASG catalysts
About Passage Bio Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2020
Employees
24
Country
US

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.41
Day high
$4.57
Day low
$4.39
Previous close
$4.40
52W high
$19.85
-77.83% from high
52W low
$4.08
2% of range
Market cap
$14.1M
EPS
$-8.0100
Beta
2.07
Shares out
3.2M
Volume
6.8K
0.14× rel vol
Avg volume
48.6K
VWAP
$4.43
Price history computed in-house
1W
-1.57%
1M
-6.58%
3M
+4.51%
1Y
-29.82%
YTD
-62.71%
SMA 50 $5.06 · below
SMA 200 $7.91 · below
52W position 2%

PASG overview

Veridion Score
73
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around PASG.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading PASG Form 4 filings
Public disclosures

Congress activity in PASG

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for PASG in the cached public ledger.

Federal contracts

PASG contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PASG in this window.
Lobbying spend

PASG lobbying filings, year to date.

Registered lobbying filings matched to Passage Bio Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PASG in this window.
Loading news for PASG
Analyst ratings
Sovereign unlock shows live analyst consensus for PASG.
Options
Sovereign unlock shows live options positioning for PASG.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.